• Return to Headlines

Acorda Therapeut Has Returned 14.3% Since SmarTrend Recommendation (ACOR)

By Nick Russo

SmarTrend identified an Uptrend for Acorda Therapeut (NASDAQ:ACOR) on December 27th, 2017 at $22.40. In approximately 3 months, Acorda Therapeut has returned 14.29% as of today's recent price of $25.60.

In the past 52 weeks, shares of Acorda Therapeut have traded between a low of $13.60 and a high of $33.00 and are now at $25.55, which is 88% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has declined 2.2%.

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Acorda Therapeut shares.

Log in and add Acorda Therapeut (ACOR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights acorda therapeut

Ticker(s): ACOR